REGENXBIO

Regenxbio

Biotech

In another reversal, FDA to reconsider Regenxbio gene therapy

The agency has reversed its previous demand that Regenxbio use an untreated control arm for the one-time Hunter syndrome candidate.

Angus Liu Jun 22, 2026 10:26am

Child jumping on trampoline

Regenxbio reaps pivotal win for Duchenne gene therapy

May 14, 2026 7:25am

step up climb ladder sky hang on rung

Regenxbio gene therapy passes interim test as pivotal data loom

Mar 12, 2026 5:49am

stack of letters mail envelopes

FDA details Regenxbio rare disease rejection

Mar 3, 2026 12:56pm

Image of a neon sign with the word no lit up next to an unlit yes

FDA rejects Regenxbio's Hunter syndrome gene therapy

Feb 9, 2026 4:05pm

Make a delay and accumulation of outstanding tasks Full stop

Brain tumor prompts FDA hold for 2 Regenxbio gene therapies

Jan 28, 2026 9:42am